Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
Viking Holdings (VIK) reported solid third-quarter 2025 results wherein both earnings and revenues surpassed the Zacks Consensus Estimate as well as improved year over year. Quarterly earnings of ...
SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ...
Viking Therapeutics completes enrollment in phase 3 VANQUISH-1 trial of VK2735 to treat metabolic disorders: San Diego Thursday, November 20, 2025, 13:00 Hrs [IST] Viking Therapeu ...
Week Study Evaluating Subcutaneous VK2735 in Adults with Obesity Enrollment Completed Ahead of Schedule and Above Target Size, Indicating Strong Interest in VK2735 ...
Wondering what you need to host an amazing dinner this year? Explore our curated list of the best entertaining essentials.
The foodie in your life deserves a treat. From drinkware and kitchen appliances to sauces and seasonings, we rounded up the ...
Skift's Travel Climate 10 spotlights travel industry leaders implementing real, measurable climate solutions beyond net-zero ...
Booker, Cardinal Mooney, Manatee, Venice win to reach regional finals on Friday, Nov. 21, 2025. Bradenton Christian loses ...
Winter is coming and so is the 2025-26 high school boys basketball season in the 337. Check out these top 25 players to watch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results